Literature DB >> 16508747

[A specific therapy for chronic depression. McCullough's Cognitive Behavioral Analysis System of Psychotherapy].

E Schramm1, F Caspar, M Berger.   

Abstract

Chronic depression is a common disorder which causes significant impairment and enormous treatment costs. Traditional pharmacological and psychological treatment approaches have shown only modest success. The Cognitive Behavioral Analysis System of Psychotherapy (CBASP) by James McCullough is the only therapy developed specifically for chronic depression. It integrates behavioral, cognitive, and interpersonal strategies. The approach is supported empirically and shown to be effective. This article presents the state of the art regarding research in psychotherapeutic treatment for chronic depression. In addition, the development of the approach and therapeutic strategies and techniques of CBASP are described.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508747     DOI: 10.1007/s00115-006-2059-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  23 in total

Review 1.  Pharmacotherapy for chronic depression.

Authors:  James H Kocsis
Journal:  J Clin Psychol       Date:  2003-08

2.  Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder.

Authors:  D L Dunner; K B Schmaling; H Hendrickson; J Becker; A Lehman; C Bea
Journal:  Depression       Date:  1996

Review 3.  Acute and maintenance treatment of chronic depression.

Authors:  D L Dunner
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

4.  Combined treatment for patients with double depression.

Authors:  I W Miller; W H Norman; G I Keitner
Journal:  Psychother Psychosom       Date:  1999       Impact factor: 17.659

5.  Early- versus late-onset dythymic disorder: comparison in out-patients with superimposed major depressive episodes.

Authors:  D N Klein; A F Schatzberg; J P McCullough; M B Keller; F Dowling; D Goodman; R H Howland; J C Markowitz; C Smith; R Miceli; W M Harrison
Journal:  J Affect Disord       Date:  1999 Jan-Mar       Impact factor: 4.839

6.  Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.

Authors:  Alan F Schatzberg; A John Rush; Bruce A Arnow; Phillip L C Banks; Janice A Blalock; Frances E Borian; Robert Howland; Daniel N Klein; James H Kocsis; Susan G Kornstein; Rachel Manber; John C Markowitz; Ivan Miller; Philip T Ninan; Barbara O Rothbaum; Michael E Thase; Madhukar H Trivedi; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2005-05

7.  Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments.

Authors:  A V Ravindran; H Anisman; Z Merali; Y Charbonneau; J Telner; R J Bialik; A Wiens; J Ellis; J Griffiths
Journal:  Am J Psychiatry       Date:  1999-10       Impact factor: 18.112

Review 8.  Effectiveness of psychotherapy and combination treatment for chronic depression.

Authors:  Bruce A Arnow; Michael J Constantino
Journal:  J Clin Psychol       Date:  2003-08

9.  Treatment for chronic depression using Cognitive Behavioral Analysis System of Psychotherapy (CBASP).

Authors:  James P McCullough
Journal:  J Clin Psychol       Date:  2003-08

Review 10.  Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s.

Authors:  Ulrich Hegerl; Anita Plattner; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-04       Impact factor: 5.270

View more
  3 in total

1.  [The various facets of psychotherapy].

Authors:  Mathias Berger
Journal:  Neuropsychiatr       Date:  2013-03-05

2.  [Overcoming treatment resistance in chronic depression : The role of inpatient psychotherapy].

Authors:  Stephan Köhler; Philipp Sterzer; Claus Normann; Mathias Berger; Eva-Lotta Brakemeier
Journal:  Nervenarzt       Date:  2016-07       Impact factor: 1.214

Review 3.  [Treatment of chronic psychiatric disorders. Ethical and anthropological aspects].

Authors:  J Valdes-Stauber
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.